[Periostosis and Crohn disease: value of methotrexate].
Pierrugues
R
R
Pansard
E
E
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D010522:Periostitis / Q000188:drug therapy / Q000209:etiology*
D000305:Adrenal Cortex Hormones; D005493:Folic Acid Antagonists; D008727:Methotrexate
Périostose engainante et maladie de Crohn: intérêt du méthotrexate.